Jin Medical International Ltd.
ZJYL
$1.85
-$0.13-6.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.98% | -0.26% | 13.43% | 15.98% | 18.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.98% | -0.26% | 13.43% | 15.98% | 18.57% |
| Cost of Revenue | 3.97% | 7.58% | 11.43% | 9.75% | 8.06% |
| Gross Profit | -35.04% | -12.85% | 17.06% | 27.39% | 37.98% |
| SG&A Expenses | -11.18% | 13.76% | 48.40% | 63.67% | 83.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 84.89% | 52.11% | 26.87% | -11.09% | -40.44% |
| Total Operating Expenses | 1.09% | 8.73% | 17.26% | 17.21% | 17.16% |
| Operating Income | -83.29% | -57.01% | -15.90% | 7.74% | 26.91% |
| Income Before Tax | -61.86% | -49.05% | -32.65% | -1.61% | 29.85% |
| Income Tax Expenses | -71.90% | -43.17% | 5.75% | 56.30% | 122.29% |
| Earnings from Continuing Operations | -59.61% | -50.20% | -38.77% | -9.66% | 18.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -174.16% | -135.14% | -23.83% | 261.47% | -- |
| Net Income | -67.59% | -54.66% | -38.30% | -5.45% | 27.71% |
| EBIT | -83.29% | -57.01% | -15.90% | 7.74% | 26.91% |
| EBITDA | -78.03% | -52.50% | -13.78% | 7.63% | 25.32% |
| EPS Basic | -67.60% | -54.76% | -38.57% | -10.31% | 15.84% |
| Normalized Basic EPS | -71.88% | -55.08% | -32.50% | -0.72% | 29.58% |
| EPS Diluted | -67.60% | -54.76% | -38.57% | -10.31% | 15.84% |
| Normalized Diluted EPS | -71.88% | -55.08% | -32.50% | -0.72% | 29.58% |
| Average Basic Shares Outstanding | 0.05% | 0.29% | 0.53% | 4.04% | 7.81% |
| Average Diluted Shares Outstanding | 0.05% | 0.29% | 0.53% | 4.04% | 7.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |